Silo Pharma (SILO) Change in Account Payables (2010 - 2013)
Silo Pharma (SILO) posted Change in Account Payables of $12699.0 for Q1 2013, up 76.64% sequentially from $7189.0 in Q4 2012.
Silo Pharma (SILO) Change in Account Payables (2010 - 2013) Analysis & Trends
Silo Pharma has reported Change in Account Payables for 4 years, with the latest figure at $12699.0 in Q1 2013.
- Quarterly Change in Account Payables changed N/A year-over-year to $12699.0 in Q1 2013, while the trailing twelve-month figure through Mar 2013 was $30672.0 (up 776.34% YoY) and the FY2012 annual result came in at $17973.0, up 413.51% from the prior year.
- Change in Account Payables grew to $12699.0 in Q1 2013 per SILO's latest filing, from $7189.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $12699.0 in Q1 2013 and troughed at -$3500.0 in Q4 2010.
- A 4-year average of $4881.7 and a median of $3500.0 in 2011 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 129.03% in 2012, down 20.91% in 2012.
- Over 4 years, Change in Account Payables stood at -$3500.0 in 2010, then surged by 200.0% to $3500.0 in 2011, then surged by 105.4% to $7189.0 in 2012, then jumped by 76.64% to $12699.0 in 2013.
- According to Business Quant data, Change in Account Payables over the past three periods registered $12699.0, $7189.0, and $8016.0 for Q1 2013, Q4 2012, and Q3 2012 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 12,699.00 |
| Mar 31, 2013 | 12,699.00 |
| Dec 31, 2012 | 7,189.00 |
| Dec 31, 2012 | 7,189.00 |
| Sep 30, 2012 | 8,016.00 |
| Sep 30, 2012 | 8,016.00 |
| Jun 30, 2012 | 2,768.00 |
| Jun 30, 2012 | 2,768.00 |
| Sep 30, 2011 | 3,500.00 |
| Sep 30, 2011 | 3,500.00 |
| Jun 30, 2011 | 3,500.00 |
| Jun 30, 2011 | 3,500.00 |
| Dec 31, 2010 | -3,500.00 |
| Dec 31, 2010 | -3,500.00 |